Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Indust/Producer Dur Alphadex First Trust | FXR | Dec 31, 2024 | 74.81 | -0.09 |
Industrial Logistics Properties Trust | ILPT | Dec 31, 2024 | 3.65 | +1.96 |
Industrial Select Sector SPDR | XLI | Dec 31, 2024 | 131.76 | -0.12 |
Industrials ETF Vanguard | VIS | Dec 31, 2024 | 254.39 | -0.17 |
Infinera | INFN | Dec 31, 2024 | 6.57 | +0.15 |
InflaRx N.V | IFRX | Dec 31, 2024 | 2.47 | -6.44 |
Inflection Point Acquisition II | IPXX | Dec 31, 2024 | 11.48 | +2.04 |
Inflection Point Acquisition II Unit | IPXXU | Dec 31, 2024 | 12.55 | 0.00 |
Infobird | IFBD | Dec 31, 2024 | 2.26 | -12.23 |
Informatica | INFA | Dec 31, 2024 | 25.93 | -0.04 |
Information Services Group | III | Dec 31, 2024 | 3.34 | 0.00 |
Information Technology ETF Vanguard | VGT | Dec 31, 2024 | 621.80 | -0.92 |
Infosys ADR | INFY | Dec 31, 2024 | 21.92 | -0.81 |
InfuSystems | INFU | Dec 31, 2024 | 8.45 | +5.63 |
ING Group ADR | ING | Dec 31, 2024 | 15.67 | +0.06 |
Ingersoll Rand | IR | Dec 31, 2024 | 90.46 | -0.07 |
Ingevity | NGVT | Dec 31, 2024 | 40.75 | +1.49 |
Ingles Markets A | IMKTA | Dec 31, 2024 | 64.44 | +1.15 |
Ingram Micro Holding Corp | INGM | Dec 31, 2024 | 19.39 | 0.00 |
Ingredion | INGR | Dec 31, 2024 | 137.56 | +0.31 |
Inhibikase Therapeutics | IKT | Dec 31, 2024 | 3.25 | +0.31 |
Inhibrx Biosciences | INBX | Dec 31, 2024 | 15.40 | +1.72 |
InMed Pharmaceuticals | INM | Dec 31, 2024 | 4.74 | +3.27 |
InMode | INMD | Dec 31, 2024 | 16.70 | +0.42 |
INmune Bio | INMB | Dec 31, 2024 | 4.67 | +0.43 |
Innate Pharma ADR | IPHA | Dec 31, 2024 | 1.84 | -5.64 |
Inno Holdings | INHD | Dec 31, 2024 | 4.71 | -1.16 |
Innodata | INOD | Dec 31, 2024 | 39.52 | -6.11 |
Innospec | IOSP | Dec 31, 2024 | 110.06 | +0.08 |
InnovAge | INNV | Dec 31, 2024 | 3.93 | -0.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.